Condition
Bronchopulmonary Dysplasia (BPD) clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Bronchopulmonary Dysplasia (BPD) clinical trials that are recruiting, at sites in 6 countries (most in United States (3), Greece (1), France (1)). By phase: Phase 4 (1), Phase 1/2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 6Countries
Newest Bronchopulmonary Dysplasia (BPD) clinical trials
All recruiting trials (8)
-
Enteral DHA and ARA Supplementation for Very Preterm Infants with BPD Risk
This study tests whether giving a specific mix of DHA and ARA through feeding helps prevent bronchopulmonary dysplasia in extremely and very preterm babies.
-
Continuing CPAP protection for extremely preterm babies to reduce BPD or death
This study tests whether keeping CPAP up to 34 weeks' PMA or for at least 2 more weeks, instead of weaning to a nasal cannula, lowers the chance of bronchopulmonary dysplasia or death by 36 weeks' PMA in babies born before 29 weeks gestation.
-
Looking at tiny particles in cord blood of babies born before 28 weeks
The team will test whether extracellular vesicles in umbilical cord blood can help predict serious complications in babies born before 28 weeks of pregnancy.
-
Long-term impact of BPD on parents and caregivers (BronQ Family)
This project will see how having a child who had bronchopulmonary dysplasia (BPD) affects parents' and caregivers' quality of life and family burden across several countries using an online questionnaire.
-
Does early red blood cell transfusion affect complications and neurodevelopment in premature infants?
This study tests whether giving blood transfusions in the first month of life in premature babies is linked to early complications like ROP, NEC, BPD, IVH, and to later neurodevelopmental outcomes.
-
Metformin treatment for premature infants with bronchopulmonary dysplasia
This study tests whether giving metformin to premature infants with bronchopulmonary dysplasia can reduce lung injury and help lungs grow.
-
Montelukast for critically ill premature infants developing bronchopulmonary dysplasia: pharmacokinetics, safety, and early efficacy
This study gives once-daily montelukast to critically ill premature infants developing bronchopulmonary dysplasia to test how the drug moves through the body, whether it is safe, and whether it helps breathing.
-
Chloride Imbalance in Very Preterm Infants
This study looks to see if abnormal blood chloride in the first 4–6 weeks of life is linked to death or long-term lung problems in babies born very early.
Related topics
Quick answers
How many Bronchopulmonary Dysplasia (BPD) clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (3 trials), Greece (1 trial), France (1 trial), Croatia (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1, Phase 1/2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.